Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

NCT00084253 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT00084253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00084253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
Not reported
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections